Revised Notice of Pre-application Teleconference for RFA-CA-16-009 "Early Detection Research Network: Biomarker Developmental Laboratories (U01)"

Notice Number: NOT-CA-16-032

Key Dates
Release Date: April 4, 2016

Related Announcements

Issued by
National Cancer Institute (NCI)


This Notice supersedes NOT-CA-16-031 and provides the corrected access information for the WebEx meeting.

The National Cancer Institute (NCI) will hold a public pre-application webinar on Thursday, April 21 at 3:00-4:00 p.m. (EST) for the following Funding Opportunity Announcement (FOA):

RFA-CA-16-009 (Reissue of RFA-CA-14-014) entitled "The Early Detection Research Network: Biomarker Developmental Laboratories (U01)"

NCI staff members involved in this FOA will provide orientation and assistance to potential applicants by explaining the goals and objectives of the Biomarker Developmental Laboratories of the Early Detection Research Network and answering questions from attendees about this FOA.

Potential applicants are encouraged to submit their questions to Dr. Sudhir Srivastava ( in advance of the webinar.

To join the webinar, follow the link below:

Join WebEx meeting
Meeting number: 734 067 717
Meeting password: Application$11

Audio for the webinar may be accessed by phoning:
1-855-244-8681 Call-in toll-free number (US/Canada) 
1-650-479-3207 Call-in toll number (US/Canada) 
Access code: 734 067 717 

Can't join the meeting? Contact support.  

Non-U.S. based investigators who will be joining the webinar by calling from abroad:
Please contact Kathy Marshall ( for toll-free phone number applicable to your specific country.

Participation in this teleconference, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-16-009.


Please direct all inquiries to:

Dr. Sudhir Srivastava, Ph.D., MPH
National Cancer Institute (NCI)
Telephone: 240-276-7028